Q3 2016
Released Nov 8, 2016, before the open
10-Q filed Nov 8, 2016, 39 days after period end · 0001144204-16-132256
Q3 2016 · 10-Q
Revenue—
Net Income-$3.24M-$3.24M N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.18-$0.18 N/M vs Q3 2015N/M vs Q2 2016
Operating Income-$3,286,220N/M
Operating Cash Flowderived-$4,049,532N/M
Free Cash Flowderived-$4,049,532N/M
What the release said
The release
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$3.24M | -$6.37M | -$4.09M | -$3.48M |
| EPS Diluted | -$0.18 | -$0.35 | -$0.32 | -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR